ÁÖ¿ä ±â¾÷À¸·Î´Â Abbott Laboratories, Boston Scientific Corporation, Medtronic, Terumo Corporation, B. Braun Melsungen AG, C. R. Bard Inc., Cook Medical Inc., Biotronik SE & Co. KG, MicroPort Scientific Corporation, St. Jude Medical (now part of Abbott), Johnson & Johnson, Cardiovascular Systems Inc., Gore Medical, InspireMD, Asahi Intecc Co., Ltd., Z-Medica µîÀÌ ÀÖ½À´Ï´Ù.
Global Drug Eluting Stents Market is estimated to be valued at US$ 8.49 Bn in 2025 and is expected to reach US$ 15.22 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.7% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
US$ 8.49 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
8.70%
2032 Value Projection:
US$ 15.22 Bn
Figure. Drug Eluting Stents Market Share (%), By Region 2025
The global drug eluting stents market has witnessed significant growth in the past few years owing to the rising prevalence of cardiovascular diseases and increasing geriatric population worldwide who are more prone to coronary heart diseases and artery blockages. Drug eluting stents are increasingly being preferred by physicians over bare metal stents due to advantages such as lower rates of restenosis. Moreover, technological advancements in design of stents and drugs coated on stent surfaces have improved clinical outcomes for patients. However, high costs of drug eluting stents compared to bare metal stents remain a major challenge for market growth.
Market Dynamics:
The global drug eluting stents market is driven by the rising geriatric population, growing burden of cardiovascular diseases, and advantages offered by drug eluting stents over bare metal stents such as lower restenosis rates. However, the high costs of drug eluting stents compared to bare metal stents can hamper the market growth. Various developments in stent technology and drug coatings are expected to present lucrative opportunities for market players. For example, bioabsorbable drug eluting stents that dissolve in the body after performing their action could witness increasing adoption. Likewise, development of stent surfaces that enhance binding of drug molecules could help reduce drug elution times and costs of treatment.
Key Features of the Study:
This report provides in-depth analysis of the global drug eluting stents market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global drug eluting stents market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Abbott Laboratories, Boston Scientific Corporation, Medtronic, Terumo Corporation, B. Braun Melsungen AG, C. R. Bard Inc., Cook Medical Inc., Biotronik SE & Co. KG, MicroPort Scientific Corporation, St. Jude Medical (now part of Abbott), Johnson & Johnson, Cardiovascular Systems Inc., Gore Medical, InspireMD, Asahi Intecc Co., Ltd., and Z-Medica
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global drug eluting stents market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug eluting stents market
Market Segmentation
By Product Type Insights (Revenue, USD Bn, 2020 - 2032)
Polymer-based Coatings
Non-biodegradable Polymers
Biodegradable Polymers
Polymer free Coatings
Micro porous Surface
Micro structured Surface
Slotted Tubular Surface
Nanoporous Surface
By Application Insights (Revenue, USD Bn, 2020 - 2032)
Coronary Artery Disease
Peripheral Artery Disease
Others
By End User Insights (Revenue, USD Bn, 2020 - 2032)
Hospitals
Cardiac Catheterization Labs
Ambulatory Surgical Centers
Others
Regional Insights (Revenue, USD Bn, 2020 - 2032)
North America
U.S.
Canada
Latin America
Brazil
Argentina
Mexico
Rest of Latin America
Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
GCC Countries
Israel
Rest of Middle East
Africa
South Africa
North Africa
Central Africa
Key Players Insights
Abbott Laboratories
Boston Scientific Corporation
Medtronic
Terumo Corporation
B. Braun Melsungen AG
C. R. Bard Inc.
Cook Medical Inc.
Biotronik SE & Co. KG
MicroPort Scientific Corporation
Jude Medical (now part of Abbott)
Johnson & Johnson
Cardiovascular Systems Inc.
Gore Medical
InspireMD
Asahi Intecc Co., Ltd.
Z-Medica
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Global Drug Eluting Stents Market, By Product Type
Global Drug Eluting Stents Market, By Application
Global Drug Eluting Stents Market, By End User
Global Drug Eluting Stents Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends
4. Global Drug Eluting Stents Market, By Product Type, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Polymer-based Coatings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Non-biodegradable Polymers
Biodegradable Polymers
Polymer free Coatings
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Micro porous Surface
Micro structured Surface
Slotted Tubular Surface
Nanoporous Surface
5. Global Drug Eluting Stents Market, By Application, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Coronary Artery Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Peripheral Artery Disease
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Drug Eluting Stents Market, By End User, 2020-2032, (USD Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Hospitals
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Cardiac Catheterization Labs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Ambulatory Surgical Centers
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Drug Eluting Stents Market, By Region, 2020 - 2032, Value (USD Bn)
Introduction
Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)